Company intelligence / Profile preview

CRT Clinical Research Technology

Ownership: Private
Development stage: Other

Overview

CRT has managed a growing number of clinical trial projects across multiple phases (I-IV) and study types. Their proprietary eClinical platform has enrolled over 10,000 patients in the last two years and is validated to US FDA 21 CFR Part 11 standards for clinical data management.

Therapeutic areas: OncologyCardiovascularInfectious DiseasesOtherNephrology
Modalities: Small moleculeBiologicMedical device
Industry: Contract Research Organization

Beyond the preview

Go deeper on CRT Clinical Research Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CRT Clinical Research Technology.

Explore the full profile